Manic Depression / Bipolar Disorder

 

A bipolar  condition with cyclic states of mania  and depression.  In 85% of cases, depression  dominates  the

personality cycle.

 

Preventing and Reversing Lithium Toxicity and Side Effects With Essential Fatty Acids

Over a decade ago, a woman visited Tahoma Clinic on the advice of her psychiatrist. She was "severely bipolar," requiring a maximum dose of lithium carbonate to keep her symptoms under control. Despite close monitoring of serum lithium levels to maintain a safe range, she was starting to show many signs of lithium toxicity, including hypertension, tremor, nausea, and proteinuria. She and her psychiatrist had tried other medications, but none provided the control of her bipolar symptoms that lithium did. As she asked: "Is there an alternative to either the psych ward or the medical wing?"

Fortunately, there was, and is. Without changing her lithium dose, she was asked to start on flaxseed oil, one tablespoon (15cc's) three times daily along with 800 IUs of vitamin E (mixed tocopherols). One month later, her blood pressure had normalized, her tremor and nausea were gone, and there was no further protein in the urine. Her bipolar symptoms remained under control. She was advised to cut the flaxseed oil to one tablespoon daily along with 400 IUs of vitamin E. Several years later, her lithium toxicity hasn't returned.

We're grateful to Dr. David Horrobin for this clinical tip. During a years-ago lecture on fatty-acid metabolism, he pointed out in passing that lithium could inhibit a vital step, but that this could be overcome by providing more "precursor" fatty acid to overwhelm that inhibition. This simple procedure works well in vivo as well as in vitro. To

be "on the safe side," a daily amount of flaxseed oil (or other essential fatty acid), along with vitamin E, should be recommended for anyone taking lithium. With low-dose lithium, a teaspoonful or two daily is usually sufficient.

 

Suggested Nutritional Supplementation

 

  • Lumina - 2 softgels daily.

Lumina is designed to support healthy mental function and relaxation-issues related to proper focus, attention, learning, and memory-through modulating the metabolism of neurotransmitters such as dopamine, gamma-aminobutyric acid (GABA), and norepinephrine.

  • Elo-Plex - 2 tablets 2 times daily with juice on an empty stomach.

Natural mood elevator

Documented benefits in both bi- and unipolar depression.

  • Flax Seed Oil - 1 tablespoon 3 times daily
  • E-Complex 1:1 - 2 softgels twice daily with meals

E Complex-1:1 is a unique, natural vitamin E supplement that features a 1:1 ratio of alpha- to gamma- tocopherol; this ratio more closely resembles the tocopherol profile found naturally in vitamin E-rich plants.

  • Wellness EssentialsTM - 1 packet twice daily.

Base nutrition with essential fatty acids and detox support.

  • Lithinase - 2-3 capsules 3 times daily with meals.

Bioavailable form of lithium documented in manic depressive cases.

Caution: Not to be used by patients taking prescription lithium

 

References

1.        Beasley J: The Betrayal of Health. The impact of nutrition, environment, and lifestyle on illness in America. Random House, New York, 1991.

2.        Fielding JE: Smoking: Health effects and control. New Eng J Med 313:491-8, 555-61, 1985.

3.        Mattson ME, Pollack ES, and Cullen JW: What are the odds smoking will kill you? Am J Publ Health 77:425-31, 1987.

4.        Carroll BJ, Curtis GC, and Mendels J: Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6:235-44, 1976.

5.        Altar C, et al: Glucocorticoid induction of tryptophan oxygenase. Biochem Pharmacol 32:979-84, 1983.

6.        Kinsman R and Hood J: Some behavioral effects of ascorbic acid deficiency. Am J Clin Nutr. 24:455-64, 1971.

7.        Chou T: Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West J Med 157:544-53, 1992.

8.        Gilliand K and Bullick W: Caffeine: A potential drug of abuse. Adv Alcohol Subst Abuse 3:53-73, 1984.

9.        Greden J, et al: Anxiety and depression associated with caffeinism among psychiatric patients. Am J. Psychiatry 131: 1089-94, 1979.

10.      Neil JF, et al: Caffeinism complicating hypersomnic depressive disorders. Compr Psychiatry 19:377-85, 1978.

11.      Charney D, Henninger G, and Jatlow P: Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42:233-43, 1984.

12.      Bolton S and Null G: Caffeine, psychological effects, use and abuse. J Orthomol Psychiatry 10:202-11, 1981.

13.      Kreitsch K, et al: Prevalence, presenting symptoms, and psychological characteristics of individuals experiencing a diet-related mood disturbance. Behav Ther 19:593-4, 1985.

14.      Christensen L: Psychological distress and diet-effects of sucrose and caffeine. J Apl Nutr 40:44-50, 1988.

15.      Martin JE and Dubbert PM: Exercise applications and promotion in behavioral medicine. J Consult Clin Psychol 50:1004-17, 1982.

16.      Weyerer S and Kupfer B: Physical exercise and psychological health. Sports Med 17:108-16, 1994.

17.                       Daniel Carr, et al: Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipoprotein in women. New Engl J. Med 305:560-5, 1981.

 

18.      Lobstein D, Mosbacher BJ and Ismail AH: Depression as a powerful discriminator between physically active and sedentary middle-aged med. J Psychosom Res 27:69-76, 1983.

19.      Folins CH and Sime WE: Physical fitness training and mental health. Am Psychologist 36:375-88, 1981.

20.      Martinsen EW: The role of aerobic exercise in the treatment of depression. Stress Med 3:93-100, 1987.

21.      Weyerer S and Kupfer B: Physical exercise and psychological health. Sports Med 17:108-16, 1994.

22.      Byrne A and Byrne DG: The effect of exercise on depression, anxiety, and other mood states: a review. J. Psychosom Res. 37:565-74, 1993.

23.      Casper RC: Exercise and mood. World Rev Nutr Diet 71:115-43, 1993.

24.      Winokur A, et al: Insulin resistance after glucose tolerance testing in patients with major depression. Am J Psychiatry 145:325-30, 1988.

25.      Wright JH, Jacisn JJ, Radin NS, et al: Glucose metabolism in unipolar depression. Br J Psychiatry 132:386-93, 1978.

26.      Hadji-Georgeopoulus A, et al: Elevated hypoglycemic index and late hyperinsulinism in symptomatic postprandial hypoglycemia. J Clin Endocrinol Metabol 50:371-6, 1980.

27.      Fabrykant M: The problem of functional hyperinsulinism on functional hypoglycemia attributed to nervous causes. Laboratory and clinical correlations. Metabolism 4: 469-79, 1955.

28.      Werbach M: Nutritional Influences on Illness: A Sourcebook of Clinical Research. Third Line Press, Tarzana, CA, 1991.

29.      Stanto JL and Keast DR: Serum cholesterol, fat intake, and breakfast consumption in the U.S. adult population. J Am Coll Nutr 8:567-72, 1989.

30.      Crellin R, Botiglieri T, and Reynolds EH: Folates and psychiatric disorders. Clinical potential. Drugs 45:623-36, 1993.

31.      Carney MWP, et al: Red cell folate concentrations in psychiatric patients. J. Affective Disorders 19:207-13, 1990.

32.      Godfrey PSA, et al: Enhancement of recovery from psychiatric illness by methyl folate. Lancet 336:392-5, 1990.

33.      Reynolds E, et al: Folate deficiency in depressive illness. Br J Psychiat 117:287-92, 1970.

34.     

12

Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B , homocysteine, and the MTHFR 677CgT polymorphism in anxiety and depression. Arch Gen Psychiatry. 2003;60:618-626.

35.      Hirashima F, Parow AM, Stoll AL, et cl. Omega-3 fatty acid treatment and T2 whole brain relaxtaion times in bipolar disorder. American Journal of Psychiatry, 2004;161;1922-1924.